Search Results 241-250 of 7748 for Fungicides

1. A Study Of Long-acting Antibodies Alone And In Combinations For Moderate To Severe Ulcerative Colitis - Mayo Clinic

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...

2. Kinetics of Clostridium Difficile Toxin PCR Positivity and Prediction of Recurrent Infection following Metronidazole or Vancomycin Therapy - Mayo Clinic

   This study is to see if PCR test developed at Mayo Clinic to diagnosis C. Difficile infections is able to predict the risk of recurrent infection. Participation ...

3. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also stop the ...

5. Antimicrobial agents - Infectious Diseases Lab - Mayo Clinic Research

   Mayo Clinic's Infectious Diseases Laboratory, led by Robin Patel, M.D., investigates antimicrobial agents to combat multidrug-resistant bacteria.

6. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of INCB059872 in participants with Ewing sarcoma who are refractory or ...

7. Crohn's disease - Doctors and departments - Mayo Clinic

   Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

8. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection - Mayo Clinic

   About this study. A Postmarketing Prospective Cohort Study of Melanoma Patients Treated With IMLYGIC® (Talimogene Laherparepvec) in Clinical Practice to ...

9. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.